Abstract
Copper(II) complexes possess relatively a broad spectrum of medicinal importance with less toxicity. It is important to note that, in this chapter, copper(II) is selected as chelating central metal atom considering its current reputation to design such bio-active compounds due to its; (i) permits in realizing stable coordination compound, (ii) diverse coordinating capability with oxygen (O), nitrogen (N), sulfur (S) and phosphorus (P) donor ligands, and (iii) exhibits potentially better biological activity. Therefore, the presented chapter offers the up-to-date advancement and future perspective of bio-active copper(II) complexes derived from Schiff base of azo- and phenyl hydrazine-based ligands and their derivatives. To showcase the existing trend of these classes of bio-active compounds, due to the wide depth of the literature, selected seminal compounds exhibiting outstanding biological activity are discussed in detail. Recent studies establish that azo- and phenyl hydrazine-based bio-active copper(II) complexes are among the promising candidates that are expected to replace the conventional antibiotics which are suffering from side effects as well as microbial resistance. However, the collaborative efforts of chemists and biotechnologists are still needed to realize their real world application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.